Antidepressant treatment with fluoxetine during pregnancy and lactation modulates the gut microbiome and metabolome in a rat model relevant to depression

Up to 10% of women use selective serotonin reuptake inhibitor (SSRI) antidepressants during pregnancy and postpartum. Recent evidence suggests that SSRIs are capable of altering the gut microbiota. However, the interaction between maternal depression and SSRI use on bacterial community composition a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramsteijn, Anouschka S, Jašarević, Eldin, Houwing, Danielle J, Bale, Tracy L, Olivier, Jocelien DA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Paper/Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524305/
https://www.ncbi.nlm.nih.gov/pubmed/31971855
http://dx.doi.org/10.1080/19490976.2019.1705728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524305/
https://www.ncbi.nlm.nih.gov/pubmed/31971855
http://dx.doi.org/10.1080/19490976.2019.1705728

Ejemplares similares